• In its first-quarter 2026 update, Huron Consulting Group reported US$451.77 million in revenue, slightly lower net income of US$23.25 million, reaffirmed full-year 2026 revenue guidance of US$1.78 billion to US$1.86 billion, and disclosed continued share repurchases under its long-running buyback program.
• Management also highlighted a disciplined shift in capital allocation between tuck-in M&A and buybacks, signaling confidence in the company’s own valuation while still pursuing selective growth acquisitions.
• Next, we’ll examine how Huron’s reaffirmed 2026 guidance and continued buybacks may influence its existing investment narrative and assumptions.

Capitalize on the AI infrastructure supercycle with our selection of the 42 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Huron Consulting Group Investment Narrative Recap

To own Huron, you need to believe its focus on healthcare, education and commercial clients can keep translating complex challenges into billable, higher value work. The key short term catalyst remains execution on demand in healthcare and digital projects, while a major risk is rising costs and integration spending outpacing revenue growth. The latest quarter’s higher revenue but slightly lower net income, alongside reaffirmed 2026 guidance, does not materially change that near term risk reward balance.

The most relevant update here is Huron’s reaffirmed 2026 revenue guidance of US$1.78 billion to US$1.86 billion, even as it slows the pace of tuck in M&A and continues sizeable buybacks. That stance keeps the focus on organic demand, particularly in health care and digital, as the main catalyst, while still acknowledging the ongoing risk that M&A integration, higher compensation and contractor costs could pressure margins if project growth softens.

Yet even with reaffirmed guidance, investors should also be aware that margin pressure from rising costs and M&A integration could...

Huron Consulting Group's narrative projects $2.1 billion revenue and $201.7 million earnings by 2029. This requires 8.8% yearly revenue growth and about a $96.7 million earnings increase from $105.0 million today.

Uncover how Huron Consulting Group's forecasts yield a $205.50 fair value, a 95% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were expecting Huron’s revenue to reach about US$2.2 billion and earnings of roughly US$214.5 million, which is far more upbeat than the baseline view. If you believe hospitals’ financial strain could slow consulting projects instead, that risk sits in sharp contrast to those bullish assumptions, and the latest results and capital allocation choices may ultimately push your own expectations closer to one side or the other.

Explore 3 other fair value estimates on Huron Consulting Group - why the stock might be worth just $205.50!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Huron Consulting Group research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Huron Consulting Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Huron Consulting Group's overall financial health at a glance.

Want Some Alternatives?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 50 companies with promising cash flow potential yet trading below their fair value.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.